Page Six exclusively spoke with a registered dietitian about the safety and efficiency of the “Kardashians” star’s latest ...

You don't often see a "science day" in a Philadelphia courtroom. But that's exactly what happened last week in a potentially ...

Some patients taking weight-loss drugs, like Ozempic, are beginning to report slower or no weight loss as their bodies build ...

In our content, we occasionally include affiliate links. Should you click on these links, we may earn a commission, though this incurs no additional cost to you. Your use of this website signifies ...

Businesses can take proactive steps now to best position themselves for a competitive advantage in the face of the seismic ...

The US Food and Drug Administration approved Ozempic in 2017 to treat Type 2 diabetes in adults and Wegovy in 2021 for adult weight loss. They are part of a class of drugs that mimic the GLP-1 ...

Ozempic, Wegovy, Mounjaro, Zepbound: Blockbuster weight loss drugs have been arguably the biggest health story of the last several years — and there are no signs their popularity will slow down ...

(NEXSTAR) – A woman who used the semaglutide drugs Wegovy and Ozempic to lose weight and treat ... runny nose and sore throat. While other gastrointestinal issues are mentioned in the 15-page ...

Analysts believe Hims & Hers will earn $0.57 per share this year and $0.80 next year. That prices the stock at 17 times next ...

Plus: GLP-1 drugs like Ozempic have potential to treat cancer, COVID-19, heart disease, and many other diseases.

Inflation might be easing in some segments of the economy, but health care costs are set to soar next year ... increased expenditures on specialty prescription drugs — particularly GLP-1 ...